Correlation Between BioInvent International and AroCell AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioInvent International and AroCell AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioInvent International and AroCell AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioInvent International AB and AroCell AB, you can compare the effects of market volatilities on BioInvent International and AroCell AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioInvent International with a short position of AroCell AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioInvent International and AroCell AB.

Diversification Opportunities for BioInvent International and AroCell AB

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between BioInvent and AroCell is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding BioInvent International AB and AroCell AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AroCell AB and BioInvent International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioInvent International AB are associated (or correlated) with AroCell AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AroCell AB has no effect on the direction of BioInvent International i.e., BioInvent International and AroCell AB go up and down completely randomly.

Pair Corralation between BioInvent International and AroCell AB

Assuming the 90 days trading horizon BioInvent International AB is expected to under-perform the AroCell AB. But the stock apears to be less risky and, when comparing its historical volatility, BioInvent International AB is 3.06 times less risky than AroCell AB. The stock trades about -0.49 of its potential returns per unit of risk. The AroCell AB is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  43.00  in AroCell AB on September 14, 2024 and sell it today you would lose (2.00) from holding AroCell AB or give up 4.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BioInvent International AB  vs.  AroCell AB

 Performance 
       Timeline  
BioInvent International 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioInvent International AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, BioInvent International is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
AroCell AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AroCell AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

BioInvent International and AroCell AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioInvent International and AroCell AB

The main advantage of trading using opposite BioInvent International and AroCell AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioInvent International position performs unexpectedly, AroCell AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AroCell AB will offset losses from the drop in AroCell AB's long position.
The idea behind BioInvent International AB and AroCell AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios